New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2014
17:04 EDTGM, C, ESNT, CX, CF, NTAP, AAPL, TEVA, LUK, YNDX, STZ, BRCD, MSFT, HAL, ABX, JPM, MWV, JNJ, HLF, DISHSoros Fund Management gives quarterly update on stakes
NEW STAKES: Essent Group (ESNT), JPMorgan (JPM), Leucadia (LUK), Citigroup (C) and Barrick (ABX). INCREASED STAKES: Teva (TEVA), General Motors (GM), Halliburton (HAL), Apple (AAPL) and Dish (DISH). DECREASED STAKES: Microsoft (MSFT), NetApp (NTAP), Herbalife (HLF), Brocade (BRCD) and CF Industries (CF). LIQUIDATED STAKES: Johnson & Johnson (JNJ), Constellation Brands (STZ), Cemex (CX), MeadWestvaco (MWV) and Yandex (YNDX).
News For ESNT;JPM;LUK;C;ABX;TEVA;GM;HAL;AAPL;DISH;MSFT;NTAP;HLF;BRCD;CF;JNJ;STZ;CX;MWV;YNDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | all recent news | >>
February 17, 2015
08:04 EDTCWuXi PharmaTech enters into loan agreement with consortium led by Citi
Subscribe for More Information
07:32 EDTAAPLApple asking suppliers to make 5M-6M Apple Watches in Q1, WSJ says
Subscribe for More Information
07:28 EDTAAPLApple design chief working on store redesign ahead of Watch, New Yorker says
Subscribe for More Information
07:22 EDTAAPL, NTAPMitsubishi UFJ to hold a tour
Subscribe for More Information
07:15 EDTAAPLApple foray into autos would be logical, says Barclays
Subscribe for More Information
07:08 EDTAAPLAuto market could be meaningful for Apple, says Cantor
Subscribe for More Information
07:04 EDTJNJGTx names Robert Wills as executive chairman
Subscribe for More Information
07:04 EDTTEVATeva, Eagle enter license agreement for EP-3102
Teva Pharmaceutical Industries (TEVA) and Eagle Pharmaceuticals (EGRX) announce that the companies have entered into an exclusive license agreement for EP-3102, Eagle’s bendamustine hydrochloride rapid infusion product for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma. Teva will be responsible for all U.S. commercial activities for the product including promotion and distribution. Eagle has responsibility for obtaining all regulatory approvals, conducting post-approval clinical studies, if required, and initially supplying drug product to Teva. As part of the agreement, Teva will waive its orphan drug exclusivities for NHL and CLL with respect to EP-3102, which should allow the product to come to market more quickly. Under the terms of the exclusive license agreement, Eagle will receive an upfront cash payment of $30M and is eligible to receive up to $90M in additional milestone payments. In addition, Eagle will receive double-digit royalties on net sales of the product, assuming FDA approval. The companies will also settle the pending patent infringement action between them.
06:57 EDTGMGM in court Tuesday over bankruptcy shield, WSJ says
Subscribe for More Information
06:48 EDTNTAPNimble Storage winning at NetApp's expense, says Piper Jaffray
Subscribe for More Information
06:39 EDTCBanks settle claims related to mortgage securities, Reuters says
Subscribe for More Information
06:15 EDTDISHCiti sees three options for DISH, including sale to Verizon
Subscribe for More Information
05:58 EDTGMGeneral Motors recalls 81,000 Malibus, Pontiacs due to power steering issue
Subscribe for More Information
05:51 EDTMSFTStocks with implied volatility below IV index mean; MSFT QCOM
Subscribe for More Information
February 16, 2015
12:50 EDTGMGM claims for ignition switch defects rises to 4,312, Reuters says
Subscribe for More Information
February 15, 2015
18:10 EDTHALValueAct buys 30M shares of Halliburton after Baker Hughes deal, Bloomberg says
ValueAct Capital has accumulated a 30M share stake in oilfield-services provider Halliburton (HAL) in addition to its holdings in peer Baker Hughes (BHI) as the investor stands behind an agreed merger of the oilfield-services providers, says Bloomberg. Reference Link
16:44 EDTAAPLApple Watch could increase revenue by 10% next year, Barron's says
Subscribe for More Information
14:18 EDTGMGM recalls 69,633 U.S. vehicles on concerns about their electric power steering
General Motors is recalling certain model year 2006-2007 Chevrolet Malibu and Malibu Maxx vehicles manufactured April 1, 2006, to June 30, 2006, and 2006-2007 Pontiac G6 vehicles manufactured April 18, 2006, to June 30, 2006. In the affected vehicles, there may be a sudden loss of electric power steering, EPS, assist that could occur at any time while driving. Reference Link
07:47 EDTAAPLHope of car positive for Apple shares, says Piper Jaffray
Piper Jaffray analyst Gene Munster said in a note to investors yesterday that the potential for a car gives investors something to look at as "the next big thing" for Apple. Munster believes the Wall Street Journal's report that Apple is building an electric car will help support the stock over the next six months. He believes it is unlikely that the company launches anything in the next five years, however. Munster reiterated an Overweight rating on Apple with a $160 price target. The stock closed Friday up 62c to $127.08.
07:46 EDTAAPLApple working on minivan-like electric vehicle, WSJ reports
Apple has "several hundred" employees working secretly toward creating an Apple-branded electric vehicle, Wall Street Journal reported yesterday, citing people familiar with the matter. The project is known internally as "Titan" and has a design that resembles a minivan, the Journal added. The Financial Times reported yesterday that the iPhone maker is recruiting experts in automotive technology and vehicle design. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use